Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ chec
 

Researchers from Rice University and Baylor College of Medicine are hoping a first-of-its-kind "glyco-immune" checkpoint inhibitor could be the key to stopping bone cancer metastasis for breast cancer survivors.

More...